OBJECTIVES: To describe the demographics, clinical manifestations, treatment, and outcomes of patients with pulmonary alveolar proteinosis (PAP) who developed an opportunistic infection with Nocardia spp., mycobacteria or fungal pathogens. METHODS: A case of PAP and Nocardia spp. brain abscess is described. A comprehensive review of the English-language literature was conducted to identify all reported cases of PAP and opportunistic infections between 1950 and July, 2010. RESULTS: Seventy five cases were reviewed. Thirty two patients (43%) had nocardial infection, 28 (37%) mycobacterial infection, and 15 (20%) fungal infection. Thirty nine patients (65%) were male. Seventeen patients (23%) were immunosuppressed. Twenty patients (27%) were active smokers. PAP was the initial diagnosis in 19 patients (33%), while infection presented first in 23 patients (40%); 16 patients (27%) had a concurrent diagnosis of PAP and infection. The average interval between PAP diagnosis and an opportunistic infection was 16 months. Lungs were the most common site of infection; extra-pulmonary infection was present in 27 patients (32%). Thirty nine patients (57%) survived through the follow-up period, while 31 died. CONCLUSIONS: Opportunistic infections can either precede or follow a diagnosis of PAP. PAP should be considered in apparently immunocompetent patients who present with an opportunistic infection and diffuse alveolar infiltrates.
OBJECTIVES: To describe the demographics, clinical manifestations, treatment, and outcomes of patients with pulmonary alveolar proteinosis (PAP) who developed an opportunistic infection with Nocardia spp., mycobacteria or fungal pathogens. METHODS: A case of PAP and Nocardia spp. brain abscess is described. A comprehensive review of the English-language literature was conducted to identify all reported cases of PAP and opportunistic infections between 1950 and July, 2010. RESULTS: Seventy five cases were reviewed. Thirty two patients (43%) had nocardial infection, 28 (37%) mycobacterial infection, and 15 (20%) fungal infection. Thirty nine patients (65%) were male. Seventeen patients (23%) were immunosuppressed. Twenty patients (27%) were active smokers. PAP was the initial diagnosis in 19 patients (33%), while infection presented first in 23 patients (40%); 16 patients (27%) had a concurrent diagnosis of PAP and infection. The average interval between PAP diagnosis and an opportunistic infection was 16 months. Lungs were the most common site of infection; extra-pulmonary infection was present in 27 patients (32%). Thirty nine patients (57%) survived through the follow-up period, while 31 died. CONCLUSIONS:Opportunistic infections can either precede or follow a diagnosis of PAP. PAP should be considered in apparently immunocompetent patients who present with an opportunistic infection and diffuse alveolar infiltrates.
Authors: Jose F Camargo; Stephen A Lobo; Amy P Hsu; Christa S Zerbe; Gary P Wormser; Steven M Holland Journal: Clin Infect Dis Date: 2013-05-31 Impact factor: 9.079
Authors: Gwo-Hsiao Chen; Seagal Teitz-Tennenbaum; Lori M Neal; Benjamin J Murdock; Antoni N Malachowski; Anthony J Dils; Michal A Olszewski; John J Osterholzer Journal: J Immunol Date: 2016-01-11 Impact factor: 5.422
Authors: Nydiaris Hernández-Santos; Darin L Wiesner; J Scott Fites; Andrew J McDermott; Thomas Warner; Marcel Wüthrich; Bruce S Klein Journal: Cell Host Microbe Date: 2018-03-22 Impact factor: 21.023
Authors: Lindsey B Rosen; Nuno Rocha Pereira; Cristóvão Figueiredo; Lauren C Fiske; Roseanne A Ressner; Julie C Hong; Kevin S Gregg; Tracey L Henry; Kirk J Pak; Katherine L Baumgarten; Leonardo Seoane; Julia Garcia-Diaz; Kenneth N Olivier; Adrian M Zelazny; Steven M Holland; Sarah K Browne Journal: Clin Infect Dis Date: 2014-12-03 Impact factor: 9.079